Nucleus first launched in March 2018 and at Datatrial our mission was to make software that makes people’s lives easier. This business mission still remains the same today and this, along with one eye always focused on our vision ‘to advance global healthcare through data expertise, innovative technology and collaborative relationships’, reminds us why we started this journey in the first place.  

So, why did we develop Nucleus? Over the course of 6 months, we will look at key stakeholders and discuss why we developed Nucleus with them in mind. Firstly, we start at the heart of the brand with Datatrial’s Head of Software Development, Jamie Pollard as he helps us answer that question, Why Nucleus?

Where did the initial idea of Nucleus derive from?

Nucleus was originally intended to be a portal for accessing third party clinical trial applications. As we started developing the platform it became apparent that we could expand the initial idea into being a much bigger repository for clinical data. Given our experience providing an EDC platform (nowEDC) we were already comfortable capturing clinical trial data, but acutely aware of the difficulties people faced when interrogating and passing that information from A to B. The main issue we now focus on is how we make clinical trial data more accessible to everyone involved in a trial, whether that is clinical documents, through dataset data and submission.

‘Your whole study, in one place’

Darren Churchill, Technical Study Delivery Manager

Did you notice a gap in the market?

I think it is clear that there is an ongoing struggle within the industry for technology that is straight forward. Historically our industry has been pretty slow at adopting technology that is popular in others, and generally just providing software that either doesn’t tie you into a single provider platform, or can be used to view information that it stored in multiple systems.

This is still the case, and there are a number of companies trying to solve the problem, but without the adoption of open APIs and the willingness to do so from the technology vendors, we could still be a long way off.

‘Nucleus takes all the hassle out of document management and puts a big tick in the compliance box’

Chelsie Brown, Inbound Marketing Manager

Who is Nucleus developed for?

Nucleus was (and still is) developed for users within the clinical trial space, who want an open, secure framework to use as a repository for their data. By providing open APIs for more technical users, as well as allowing data interrogation via more standard applications such as Power BI we can prevent the complexity of data being handed from point to point before being available for analysis. This in turn provides a faster route to the information our users require, to identify trends and anomalies in their data and react to them without the complexity that may have been there previously.

‘Nucleus is a great example of how an initial business vision and idea can adapt and grow when working closely with strategic partners in a co-development relationship.  Our partners have played a big part in making Nucleus the successful product it is today’ 

Julie Wright, Commercial Director

How does Nucleus differ from competitors?

Our core goal with Nucleus is to always be an open framework, allowing ingress and egress of data in a simple, secure manner. Whether that data is documents, datasets, or otherwise we still strive to provide the simplest solution to the problem at hand, without users having to combine multiple expensive products or pay large platform fees.

‘Nucleus consolidates everything you need to successfully run a clinical trial within one compliant and easy to use platform’

Liam Richardson, Senior UI Developer

Check out the infographic for more information